Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Dermatology

  Free Subscription


02.01.2023

4 BMC Cancer
3 Cancer
5 Int J Cancer
1 Int J Dermatol
1 Intern Med
3 J Dermatol
5 J Invest Dermatol
2 Plast Reconstr Surg
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. YANG H, Xu L, Guan S, Hao X, et al
    Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial.
    BMC Cancer. 2022;22:1357.
    PubMed         Abstract available

  2. QI WX, Cao L, Zheng S, Xu C, et al
    IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.
    BMC Cancer. 2022;22:1356.
    PubMed         Abstract available

  3. BEATTY L, Kemp E, Butow P, Girgis A, et al
    Finding My Way-Advanced: can a web-based psychosocial intervention improve the mental quality of life for women with metastatic breast cancer vs attention-control? Study protocol of a randomised controlled trial.
    BMC Cancer. 2022;22:1353.
    PubMed         Abstract available

  4. MAHTANI R, Niyazov A, Arondekar B, Lewis K, et al
    Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2-negative advanced breast cancer from th
    BMC Cancer. 2022;22:1343.
    PubMed         Abstract available


    Cancer

  5. MALLARD J, Hucteau E, Schott R, Trensz P, et al
    Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer.
    Cancer. 2022 Nov 17. doi: 10.1002/cncr.34533.
    PubMed         Abstract available

  6. VALLANCE JK, Friedenreich CM, Wang Q, Matthews CE, et al
    Associations of device-measured physical activity and sedentary time with quality of life and fatigue in newly diagnosed breast cancer patients: Baseline results from the AMBER cohort study.
    Cancer. 2022 Nov 11. doi: 10.1002/cncr.34531.
    PubMed         Abstract available

  7. RAMADAS K, Basu P, Mathew BS, Muwonge R, et al
    Effectiveness of triennial screening with clinical breast examination: 14-years follow-up outcomes of randomized clinical trial in Trivandrum, India.
    Cancer. 2023;129:272-282.
    PubMed         Abstract available


    Int J Cancer

  8. CARIOLOU M, Abar L, Aune D, Balducci K, et al
    Postdiagnosis recreational physical activity and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
    Int J Cancer. 2022 Oct 24. doi: 10.1002/ijc.34324.
    PubMed         Abstract available

  9. TSILIDIS KK, Cariolou M, Becerra-Tomas N, Balducci K, et al
    Postdiagnosis body fatness, recreational physical activity, dietary factors and breast cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading.
    Int J Cancer. 2022 Oct 24. doi: 10.1002/ijc.34320.
    PubMed         Abstract available

  10. CHAN DSM, Vieira R, Abar L, Aune D, et al
    Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta-analysis.
    Int J Cancer. 2022 Oct 24. doi: 10.1002/ijc.34322.
    PubMed         Abstract available

  11. BAHAR-SHANY K, Barnabas GD, Deutsch L, Deutsch N, et al
    Proteomic Signature for Detection of High Grade Ovarian Cancer in germline BRCA mutation carriers.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34318.
    PubMed         Abstract available

  12. XIA C, Yu XQ, Chen W
    Measuring population-level cure patterns for cancer patients in the United States.
    Int J Cancer. 2023;152:738-748.
    PubMed         Abstract available


    Int J Dermatol

  13. BARTLEY BR, Moore SA, Doan HQ, Rady PL, et al
    Current treatments and emerging therapies of human polyomavirus-associated skin diseases: a comprehensive review.
    Int J Dermatol. 2022 Dec 28. doi: 10.1111/ijd.16534.
    PubMed         Abstract available


    Intern Med

  14. SAIKI T, Harada A, Suekane H, Torisu T, et al
    Multiple Gastrointestinal Angiosarcoma Mimicking Kaposi's Sarcoma.
    Intern Med. 2022 Dec 28. doi: 10.2169/internalmedicine.1177.
    PubMed        


    J Dermatol

  15. SAEKI H, Mabuchi T, Asahina A, Abe M, et al
    English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).
    J Dermatol. 2022 Dec 29. doi: 10.1111/1346-8138.16691.
    PubMed         Abstract available

  16. HAN J, Stratman S, Young JN, Poplausky D, et al
    Unique protein signatures evolve during the course of a delayed-type hypersensitivity reaction in human skin.
    J Dermatol. 2022 Dec 28. doi: 10.1111/1346-8138.16688.
    PubMed         Abstract available

  17. MELIN A, Bouchereau S, Guelimi R, Bergqvist C, et al
    Safety and efficacy of high-dose clobetasol propionate 0.05% in cutaneous lichen planus.
    J Dermatol. 2022 Dec 28. doi: 10.1111/1346-8138.16689.
    PubMed         Abstract available


    J Invest Dermatol

  18. OLSSON-BROWN A, Yip V, Ogiji ED, Jolly C, et al
    TNF-alpha mediated keratinocyte expression and release of matrix metalloproteinase 9: putative mechanism of pathogenesis in Stevens-Johnson syndrome/ toxic epidermal necrolysis.
    J Invest Dermatol. 2022 Dec 26:S0022-202X(22)02898.
    PubMed         Abstract available

  19. POLUBOTHU S, Bender N, Muthiah S, Zecchin D, et al
    PTPN11 mosaicism causes a spectrum of pigmentary and vascular neurocutaneous disorders and predisposes to melanoma.
    J Invest Dermatol. 2022 Dec 22:S0022-202X(22)02891.
    PubMed         Abstract available

  20. LADA G, Chinoy H, Talbot PS, Warren RB, et al
    The Relationship of Depression and Systemic Inflammation in Psoriasis; Findings from the UK Biobank.
    J Invest Dermatol. 2022 Dec 22:S0022-202X(22)02894.
    PubMed        

  21. YI-PIN LEE C, Carissimo G, Teo TH, Ming Tong SJ, et al
    CD8+ T-cells trigger auricular dermatitis and blepharitis in mice post-Zika virus infection in the absence of CD4+ T-cells.
    J Invest Dermatol. 2022 Dec 22:S0022-202X(22)02893.
    PubMed         Abstract available

  22. AFACH S, Le Cleach L, Sbidian E
    Placebo response in moderate-to-severe psoriasis: prevalence meta-analysis of randomised controlled trials.
    J Invest Dermatol. 2022 Dec 20:S0022-202X(22)02892.
    PubMed        


    Plast Reconstr Surg

  23. PANAHI A, Couch KS, White PB, Chao JW, et al
    Acute Skin Failure Associated with Severe COVID-19.
    Plast Reconstr Surg. 2023;151:185e-186e.
    PubMed        

  24. PETERS BR, Richards HW, Berli JU
    Optimizing Innervation in Radial Forearm Phalloplasty: Consider the Posterior Antebrachial Cutaneous Nerve.
    Plast Reconstr Surg. 2023;151:202-206.
    PubMed         Abstract available


    PLoS One

  25. PIERA-VELAZQUEZ S, Dillon ST, Gu X, Libermann TA, et al
    Aptamer proteomics of serum exosomes from patients with Primary Raynaud's and patients with Raynaud's at risk of evolving into Systemic Sclerosis.
    PLoS One. 2022;17:e0279461.
    PubMed         Abstract available

  26. CHOUPANI E, Madjd Z, Saraygord-Afshari N, Kiani J, et al
    Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells.
    PLoS One. 2022;17:e0279522.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  27. CHEN X, Sifakis EG, Robertson S, Neo SY, et al
    Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction.
    Proc Natl Acad Sci U S A. 2023;120:e2209856120.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: